We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current 1AD market cap is 8.52M. The company's latest EPS is AUD -0.0101 and P/E is -1.98.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 3.83M | 3.98M | 2.75M | 3.47M | 1.74M |
| Operating Income | -5.84M | -5.42M | -6M | -4.87M | -5.32M |
| Net Income | -6.01M | -5.63M | -6.06M | -4.85M | -5.38M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 6.91M | 9.05M | 10.65M | 7.73M | 5.57M |
| Total Liabilities | 3.21M | 2.66M | 5.27M | 5.82M | 3.54M |
| Total Equity | 3.7M | 6.39M | 5.38M | 1.91M | 2.03M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -5.89M | -4.78M | -4.09M | -5.13M | -5.26M |
| Investing | -2k | -2k | -25k | -2k | -62k |
| Financing | 3.7M | 7.2M | 7.02M | 1.27M | 3.67M |
| Market Cap | 8.52M |
| Price to Earnings Ratio | -1.98 |
| Price to Sales Ratio | 6.06 |
| Price to Cash Ratio | 3.39 |
| Price to Book Ratio | 5.25 |
| Dividend Yield | - |
| Shares Outstanding | 532.62M |
| Average Volume (1 week) | 512.96k |
| Average Volume (1 Month) | 400.78k |
| 52 Week Change | -36.00% |
| 52 Week High | 0.041 |
| 52 Week Low | 0.013 |
| Spread (Intraday) | 0 (16.67%) |
| Company Name | AdAlta Limited |
| Address |
unit 15 melbourne, victoria 3083 |
| Website | https://www.adalta.com.au |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
